UnitedHealth Group Incorporated (NYSE:UNH) is First Manhattan CO. LLC.’s 9th Largest Position

First Manhattan CO. LLC. trimmed its position in shares of UnitedHealth Group Incorporated (NYSE:UNHFree Report) by 2.2% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,522,998 shares of the healthcare conglomerate’s stock after selling 34,421 shares during the period. UnitedHealth Group comprises 2.3% of First Manhattan CO. LLC.’s holdings, making the stock its 9th biggest holding. First Manhattan CO. LLC.’s holdings in UnitedHealth Group were worth $770,550,000 at the end of the most recent quarter.

A number of other hedge funds have also recently modified their holdings of the business. NewSquare Capital LLC purchased a new stake in UnitedHealth Group in the 4th quarter valued at about $25,000. Marshall & Sterling Wealth Advisors Inc. purchased a new stake in shares of UnitedHealth Group in the 4th quarter worth $26,000. Hurley Capital LLC bought a new stake in shares of UnitedHealth Group in the 4th quarter valued at about $28,000. AlphaMark Advisors LLC bought a new position in UnitedHealth Group in the fourth quarter worth approximately $30,000. Finally, Aster Capital Management DIFC Ltd purchased a new stake in shares of UnitedHealth Group during the fourth quarter valued at about $30,000. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Trading Down 1.4 %

UNH opened at $385.74 on Friday. The business’s 50 day moving average is $489.89 and its two-hundred day moving average is $523.90. The firm has a market cap of $351.11 billion, a price-to-earnings ratio of 24.89, a price-to-earnings-growth ratio of 1.37 and a beta of 0.56. UnitedHealth Group Incorporated has a 52 week low of $385.37 and a 52 week high of $630.73. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNHGet Free Report) last posted its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing analysts’ consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company had revenue of $109.58 billion for the quarter, compared to analyst estimates of $111.56 billion. During the same period in the previous year, the business posted $6.91 earnings per share. On average, research analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were paid a $2.10 dividend. The ex-dividend date was Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a yield of 2.18%. UnitedHealth Group’s payout ratio is 35.18%.

Analyst Ratings Changes

Several equities research analysts have weighed in on the company. HSBC reissued a “hold” rating and issued a $490.00 price target on shares of UnitedHealth Group in a report on Tuesday, April 22nd. Argus lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Monday, April 21st. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $700.00 price target on shares of UnitedHealth Group in a report on Friday, January 17th. Wells Fargo & Company decreased their target price on shares of UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating for the company in a research note on Tuesday, January 28th. Finally, Royal Bank of Canada dropped their target price on UnitedHealth Group from $655.00 to $525.00 and set an “outperform” rating on the stock in a research report on Wednesday, April 23rd. Four analysts have rated the stock with a hold rating, nineteen have assigned a buy rating and two have assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, UnitedHealth Group presently has an average rating of “Moderate Buy” and an average target price of $596.86.

Get Our Latest Stock Report on UnitedHealth Group

About UnitedHealth Group

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Featured Articles

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHFree Report).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.